These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 15574056)

  • 1. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of adverse events following immunisation: Australia, 2000-2002.
    Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
    Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
    Lawrence GL; Boyd I; McIntyre PB; Isaacs D
    Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual report on surveillance of adverse events following immunisation in Australia, 2006.
    Lawrence GL; Aratchige PE; Boyd I; McIntyre PB; Gold MS
    Commun Dis Intell Q Rep; 2007 Sep; 31(3):269-82. PubMed ID: 17974219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual report: surveillance of adverse events following immunisation in Australia, 2007.
    Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB
    Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
    Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
    Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual report: surveillance of adverse events following immunisation in Australia, 2009.
    Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI
    Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of adverse events following immunisation in Australia annual report, 2013.
    Mahajan D; Dey A; Cook J; Harvey B; Menzies R; Macartney K
    Commun Dis Intell Q Rep; 2015 Sep; 39(3):E369-86. PubMed ID: 26620351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of adverse events following immunisation in Australia annual report, 2017.
    Dey A; Wang H; Quinn H; Hiam R; Wood N; Beard F; Macartney K
    Commun Dis Intell (2018); 2019 Jul; 43():. PubMed ID: 31315166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual report: surveillance of adverse events following immunisation in Australia, 2010.
    Mahajan D; Cook J; McIntyre PB; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2011 Dec; 35(4):263-80. PubMed ID: 22624487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following immunization in Ontario's female school-based HPV program.
    Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
    Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of adverse events following immunisation in Australia: annual report, 2018.
    Dey A; Wang H; Quinn H; Pillsbury A; Glover C; Hickie M; Wood N; Beard F; Macartney K
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
    Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
    Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of adverse events following immunisation in Australia annual report, 2014.
    Dey A; Wang H; Quinn HE; Hill R; Macartney KK
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E377-E390. PubMed ID: 28278414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
    Masuka JT; Khoza S
    BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.